LBA4 GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an anti-PDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC)
Caicun Zhou, Z. Wang, Yehuan Sun, L. Cao, Z. Ma, Rong Wu, Yan Yu, W. Yao, J. Chang, J. Chen, W. Zhuang, Jiuwei Cui, Xudong Chen, You Lü, Huahao Shen, P. Li, J. Wang, Bei Sun, Dongmei Lu, J. Yang
Topics & Concepts
MedicinePlaceboInterim analysisInternal medicinePemetrexedClinical endpointPhases of clinical researchnon-small cell lung cancer (NSCLC)ChemotherapyLung cancerOncologyGastroenterologyClinical trialPathologyCisplatinA549 cellAlternative medicinePeptidase Inhibition and AnalysisMonoclonal and Polyclonal Antibodies ResearchCancer Immunotherapy and Biomarkers